CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 0.205
- 0.0000.00%
15min DelayMarket Closed May 28 16:00 ET
47.04MMarket Cap-6833P/E (TTM)
0.205High0.205Low1.02KVolume0.205Open0.205Pre Close209.00Turnover0.26052wk High0.00%Turnover Ratio229.44MShares0.15052wk Low-0.03EPS TTM39.00MFloat Cap8.050Historical HighLossP/E (Static)190.22MShs Float0.060Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-205.00P/B1Lot Size--Div YieldTTM
About Helix BioPharma Corp Company
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Company Profile
SymbolHBP
Company NameHelix BioPharma Corp
Founded1995
MarketTSE
Employees10
Fiscal Year Ends07-31
Address 401 Bay Street Suite 2704
CityToronto
CountryCAN
Zip CodeM5H 2Y
Phone+1 905 841-2300
Company Executives
- Name
- Position
- Salary
- Jacek Antas
- Chairman of the Board and Chief Executive Officer
- --
- Christof Boehler
- Chief Business Development Officer
- --
- Dr. Srikanth Sola
- Chief Strategy Officer
- --
- Hatem Kawar
- Chief Financial Officer
- --
- Frank Gary Renshaw
- Chief Medical Officer
- --
- Janusz Grabski
- Independent Director
- --
- Jerzy Leszczynski
- Independent Director
- --
- Margaret Irene Laube
- Independent Director
- --
- Namrata Malhotra
- Corporate Secretary
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg